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Background: The prognosis of bacterial meningitis largely depends on the severity of the inflammatory response. The
transcription factor CAAT/enhancer-binding protein δ (C/EBPδ) plays a key role in the regulation of the inflammatory
response during bacterial infections. Consequently, we assessed the role of C/EBPδ during experimental meningitis.
Methods: Wild-type and C/EBPδ-deficient mice (C/EBPδ−/−) were intracisternally infected with Streptococcus pneumoniae
and sacrificed after 6 or 30 h, or followed in a survival study.
Results: In comparison to wild-type mice, C/EBPδ−/− mice showed decreased bacterial loads at the primary site of
infection and decreased bacterial dissemination to lung and spleen 30 h after inoculation. Expression levels of the
inflammatory mediators IL-10 and KC were lower in C/EBPδ−/− brain homogenates, whereas IL-6, TNF-α, IL-1β, and MIP-2
levels were not significantly different between the two genotypes. Moreover, C/EBPδ−/− mice demonstrated an
attenuated systemic response as reflected by lower IL-10, IL-6, KC, and MIP-2 plasma levels. No differences in clinical
symptoms or in survival were observed between wild-type and C/EBPδ−/− mice.
Conclusion: C/EBPδ in the brain drives the inflammatory response and contributes to bacterial dissemination during
pneumococcal meningitis. C/EBPδ does, however, not affect clinical parameters of the disease and does not confer a
survival benefit.
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Bacterial meningitis remains an important cause of mor-
tality and morbidity worldwide, despite the implementa-
tion of vaccination strategies, effective antibiotic therapy
and adjunctive dexamethasone treatment [1,2]. Pneumo-
coccal meningitis is the most common and most severe
form of meningitis: 16% to 35% of the patients die and
up to 50% of survivors suffer from long-term sequelae,
including hearing loss, cognitive impairment, and focal
neurological deficits [3,4]. The pathophysiology of bac-
terial meningitis is characterized by a strong inflamma-
tory response in the subarachnoid space, and this host* Correspondence: d.vandebeek@amc.uva.nl
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unless otherwise stated.inflammatory response seems to cause adverse events
during bacterial meningitis [5,6]. The severity of the in-
flammatory response largely has been shown to deter-
mine the prognosis in experimental pneumococcal
meningitis [7] and novel therapeutic agents may thus
target the inflammatory response. However, the inflam-
matory response during meningitis is complex and has
only been partially elucidated.
CAAT/enhancer-binding protein δ (C/EBPδ), a member
of the C/EBP family of transcription factors that is upregu-
lated during the acute phase response, recently emerged
as an essential player in the inflammatory response to bac-
terial infections [8]. C/EBPδ levels rapidly increase after
pro-inflammatory stimuli such as lipopolysaccharide
(LPS), interleukin (IL)-1, IL-6, interferon γ (IFN-γ), and
tumor necrosis factor-α (TNF-α) [9-11]. Reciprocally, C/
EBPδ enhances cytokine production and C/EBPδ-inducedhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0) which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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infectious disease. C/EBPδ was shown to limit bacterial dis-
semination and prolong survival during a lethal model of
Escherichia coli-induced peritonitis and during Klebsiella
pneumoniae-induced pulmonary infection [12,13]. During
Streptococcus pneumoniae-induced pulmonary infection,
however, C/EBPδ exaggerated bacterial dissemination and
wild-type mice succumbed earlier to the disease as com-
pared to C/EBPδ−/− mice [14]. Furthermore, C/EBPδ did
not affect disease progression during non-lethal models of
E. coli-induced peritonitis or urinary tract infection [12,15].
C/EBPδ therefore seems to play a complex and potential
dual role during infectious disease most likely depending
on the causing pathogen, the severity of the infection and
the infection site. In the present study, we assessed the role
of C/EBPδ in experimental pneumococcal meningitis.
Materials and methods
Mice
Eight- to 12-week-old female C57BL/6 mice were ob-
tained from Charles River (Sulzfeld, Germany), whereas
C/EBPδ−/− mice, generated as described previously [16],
were bred and maintained at the animal facility at the
Academic Medical Center of Amsterdam. The mice were
kept to a controlled 12 h light/dark cycle and food and
water were provided ad libitum. All experiments were ap-
proved by the Institutional Animal Care and Use Commit-
tee of the Academic Medical Center, Amsterdam.
Experimental pneumococcal meningitis model
Pneumococcal meningitis was induced by intracisternal in-
oculation with S. pneumoniae (serotype 3, American Type
Culture Collection #6303; Rockville, MD) as described pre-
viously [17]. In brief, wild-type and C/EBPδ−/− mice (n = 12
per group) were inoculated with 1 μL bacterial suspension
containing 1 × 104 CFU S. pneumoniae into the cisterna
magna under isoflurane anesthesia. Six mice per group in-
oculated with sterile saline were used as controls. Immedi-
ately after intracisternal inoculation, mice were assessed for
neurologic damage as a result of the puncture, and if
present, these mice were excluded from further analysis.
Clinical signs of meningitis were scored at 24 and 30 h post
infection as previously described [17]. At 6 and 30 h post
infection, mice were anesthetized by intraperitoneal injec-
tion of 190 mg/kg ketamine (Eurovet Animal Health,
Bladel, The Netherlands) and 0.3 mg/kg dexmedetomidine
(Pfizer Animal Health, Capelle aan den Ijssel, The
Netherlands) followed by cardiac puncture for blood collec-
tion and perfusion of organs with sterile isotonic saline via
the left ventricle. CSF was collected by puncture of the cis-
terna magna. Brain, lung, and spleen were harvested, placed
on ice, processed, and stored as described before [17].
EDTA blood was centrifuged at 2,000×g for 15 min. Plasma
was stored at −80°C for further analysis.Determination of cytokines and chemokines
The cytokines IL-1β, IL-6, IL-10, and TNF-α and the chemo-
kines KC and MIP-2 were determined in plasma and brain
homogenates by Luminex technology using a mouse Bioplex
kit (Bio-Rad Laboratories, Veenendaal, The Netherlands) as
described before [17].
Organ damage markers
Plasma aspartate aminotransferase, alanine aminotransfer-
ase, and lactate dehydrogenase levels were determined as
described before [18].
Murine histopathology and immunohistochemistry
Histopathology was performed on the right cerebral hemi-
sphere fixed in 4% paraformaldehyde and paraffin embed-
ded. Coronal 5-μm-thick sections of the right hemisphere
were cut for subsequent staining with hematoxylin and
eosin (HE) according to standard procedures. Tissue sec-
tions were stained for C/EBPδ using immunohistochemical
procedures, as described previously [14].
Real-time PCR
Total RNA was extracted from snap frozen murine brain
homogenates using TriPure reagent (Sigma-Aldrich, St-
Louis, MO, USA). For complementary DNA (cDNA)
synthesis, RNA was treated with RQ1 RNase-free DNase
(Promega, Leiden, The Netherlands) and reverse transcribed
with SuperScript II Reverse Transcriptase and randomhexa-
mers (Life Technologies, Bleiswijk, The Netherlands). The
real-time polymerase chain reaction (RT-PCR) measure-
ment of individual cDNAs was performed on a Bio-Rad
MyiQ Single-Color RT-PCR Detection System using the
Bio-Rad iQ SYBR Green Supermix (Bio-Rad Laboratories,
Hercules, CA, USA). The c/ebpδ and Non-POU-domain
containing octamer binding protein (NoNo, housekeeping
gene), primers were described previously [14,19]. The ex-
pression data were normalized to the NoNo reference gene.
Statistical analysis
Differences between groups were analyzed using the
Mann-Whitney U-test. For the survival experiment, a
Kaplan-Meier analysis was performed using the log-rank
test. For all analyses, a P value of <0.05 was considered to
be a significant difference.
Results
C/EBPδ expression is increased during pneumococcal
meningitis
To obtain insight into the expression of C/EBPδ during
meningitis caused by S. pneumoniae, we measured c/ebpδ
mRNA levels in brain tissue from wild-type mice intracis-
ternally inoculated with 1 × 104 CFU. c/ebpδ mRNA ex-
pression was low in uninfected brain, slightly increased at
6 h after S. pneumoniae inoculation, although this did not
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about tenfold increased at 30 h after infection (Figure 1A).
Immunohistochemistry confirmed the mRNA data, and
showed increased C/EBPδ expression in the brains of in-
fected mice over time (Figure 1B,C,D). C/EBPδ was
strongly expressed in the endothelium (both in brain par-
enchyma and meninges), ependymal and choroid plexus,
and, to a lesser extent, in glia and arachnoidal cells.
C/EBPδ deficiency limits bacterial dissemination during
pneumococcal meningitis
To determine the role of C/EBPδ on bacterial dissemin-
ation during pneumococcal meningitis, we determined
bacterial loads at 6 and 30 h after infection. At 6 h after
inoculation, bacterial outgrowth in both CSF and brain
homogenates from C/EBPδ−/− mice was similar to that
observed in wild-type mice (Figure 2A). Dissemination
of bacteria into the bloodstream and to distal organs
was also similar in both groups (Figure 2B,C). At 30 h
after inoculation, bacterial loads were significantly in-
creased compared to the 6-h time point. C/EBPδ−/− mice
had lower bacterial counts in brain (median 9.5 × 107
CFU/ml vs. 2.7 × 107 CFU/ml for wild-type and C/EBPδ−/−
mice, respectively, P = 0.02) consistent with a trend toward
lower bacterial loads in blood of C/EBPδ−/− mice (median
5.0 × 104 vs. 1.1 × 104 for wild-type and C/EBPδ−/− mice,Figure 1 Pneumococcal meningitis induces C/EBPδ expression. c/ebpδ mRNA
time points after intracisternal inoculation with S. pneumoniae. Arrows indicate
and meningeal cells. Arrowheads indicate glial cells in brain parenchyma expre
plexus (CP). Original magnification ×10, inset ×20. Data are expressed as media
n = 12 at both t = 6 and t = 30 h post infection). **P < 0.01.respectively, P = 0.06) and lower bacterial numbers in
lung (median 7.7 × 104 vs. 2.0 × 104 for wild-type and
C/EBPδ−/− mice, respectively, P = 0.001) and spleen (me-
dian 1.9 × 105 vs. 3.1 x 104 for wild-type and C/EBPδ−/−
mice, respectively, P = 0.0004) of C/EBPδ−/− mice. In CSF,
bacterial counts were similar between wild-type and
C/EBPδ−/− mice (median 7.0 × 109 vs. 2.0 × 109 for wild-
type and C/EBPδ−/− mice, respectively, P = 0.20). Overall,
these results show that C/EBPδ deficiency limits bacterial
growth and dissemination during pneumococcal meningi-
tis at the later stages of the disease.C/EBPδ deficiency attenuates cytokine and chemokine
production during pneumococcal meningitis
To determine whether C/EBPδ influences inflammation
associated with pneumococcal meningitis, we assessed the
impact of C/EBPδ deficiency on the inflammatory host re-
sponse. At 6 h post infection, the extent of inflammation
both locally in the brain and systemically in plasma did not
differ between both genotypes (Figure 3). At 30 h post in-
fection, IL-10 and KC levels were lower in C/EBPδ−/− brain
homogenates, whereas brain IL-6, TNF-α, IL-1β, and MIP-
2 levels were not significantly different between the two
genotypes. C/EBPδ deficiency attenuated the systemic in-
flammatory response as reflected by lower IL-10, IL-6, KC,(A) and protein expression in wild-type brain tissue (B,C,D) at different
epithelial cells expressing C/EBPδ in vessels of the brain parenchyma (BP)
ssing C/EBPδ (BP). Asterisk indicate C/EBPδ positive cells in the choroid
n with interquartile ranges and 5% to 95% percentiles (n = 6 for controls;
Figure 2 C/EBPδ−/− mice have less bacterial outgrowth in brain, lung, and spleen at 30 h after pneumococcal meningitis. Bacterial outgrowth in CSF
and brain homogenates (A), whole blood (B), lung homogenates and spleen homogenates (C) of wild-type (open boxes) and C/EBPδ−/− (gray boxes)
6 and 30 h after infection. Data are expressed as median with interquartile ranges and 5% to 95% percentiles (n = 12 per group). **P < 0.01 compared
to wild-type mice.
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pared to wild-type mice.
To assess whether the inflammatory response is a
mere reflection of the bacterial load, cytokine/
chemokine levels were correlated with the bacterial
burden in brains of wild-type and C/EBPδ−/− mice.
As shown in Table 1, cytokine/chemokine levels and
bacterial counts were strongly correlated in wild-
type mice with correlation coefficients ranging from
0.39 to 0.84. Only TNF-α, IL-1β, and MIP-2 levels
correlated with bacterial loads in C/EBPδ−/− mice
(correlation coefficients of 0.44 to 0.68), whereas
levels of IL-6, IL-10, and KC did not show any
correlation.C/EBPδ does not affect clinical outcome of pneumococcal
meningitis
Severe bacterial meningitis leads to several clinical
(neurological) symptoms such as disorientation, par-
alysis, and an increased breathing frequency. In
order to assess whether the diminished bacterial
loads and the reduced cytokine levels in C/EBPδ−/−
mice would limit disease progression, these specific
clinical symptoms were scored at 24 and 30 h post
infection. As shown in Figure 4, clinical scores sig-
nificantly increased over time during infection reach-
ing the maximum score of 15 in some mice at 30 h
post infection. This increase was, however, similar in
wild-type and C/EBPδ−/− mice.
Figure 3 C/EBPδ deficiency modifies the inflammatory response during pneumococcal meningitis. Cytokine (A,B,C,D) and chemokine (E,F) levels
in brain homogenates and plasma of wild-type (open boxes) and C/EBPδ−/− (gray boxes) mice 6 and 30 h after infection. Data are expressed as
median with interquartile ranges and 5% to 95% percentiles (n = 11 to 12 per group). *P < 0.05 compared to wild-type control mice.
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general markers of tissue injury, we next assessed
lactate dehydrogenase (LDH), aspartate transaminase
(ASAT), and alanine transaminase (ALAT) levels. As
shown in Figure 5A,B,C, ASAT and ALAT levels signifi-
cantly increased in wild-type animals during S. pneumo-
niae infection, whereas LDH was not induced during
meningitis. ASAT and ALAT levels increased to similar
extent in C/EBPδ−/− mice.
During bacterial meningitis, destruction of the blood-
brain barrier is related to disease progression and sub-
sequent survival [7]. In order to get insight into the
blood-brain barrier status during meningitis, the brain/
plasma albumin ratio was determined for wild-type and
C/EBPδ−/− mice. As shown in Figure 6A, the albumin
ratio was not different between the two genotypes sug-
gesting that C/EBPδ deficiency does not affect the dis-
ruption of the blood-brain barrier during meningitis.We next assessed whether the observed C/EBPδ-
dependent increased bacterial loads and cytokine levels
affected survival. In the survival study, the first mice
succumbed at 32 h post infection and all mice died
within 56 h post infection (Figure 6B). There was no
difference in survival between wild-type and knockout
mice.
Discussion
This study shows that C/EBPδ expression in the brain
is induced during pneumococcal meningitis and that
C/EBPδ contributes to bacterial colonization of the brain
and dissemination to distant organs during disease progres-
sion. Although C/EBPδ potentiates the pro-inflammatory
response during meningitis, it does not modify clinical pa-
rameters of disease severity nor does it affect mortality.
The observed increase in C/EBPδ expression during
meningitis is in line with increased C/EBPδ expression
Table 1 Correlation of cytokine/chemokine levels with
bacterial outgrowth of wild-type and C/EBPδ−/− mice
upon meningitis
Brain (30 h after inoculation)
Wild type C/EBPδ−/−
(n = 11) (n = 12)
Cytokines (r2) P value (r2) P value
IL-6 0.7223 0.0009 0.0499 0.4853
TNF-α 0.3922 0.0393 0.4356 0.0271
IL-1β 0.3922 0.0393 0.4356 0.0271
IL-10 0.5679 0.0074 0.0405 0.5303
Chemokines
KC 0.8320 <0.0001 0.2704 0.1011
MIP-2 0.8405 <0.0001 0.6779 0.0010
Data were obtained using a Pearson correlation analysis and presented as
linear regression values for each group (r2) and concomitant P values.
Significant correlations (P < 0.05) are in italic. Non-significant values are shown
in gray.
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was previously shown to be increased during peritonitis
[12], pneumonia [14,13], and urinary tract infection [15].
However, the consequence of increased C/EBPδ expression
in infectious disease seems not to be straightforward as it
correlates with increased survival in some models and with
decreased survival in others. During E. coli-induced peri-
tonitis, C/EBPδ limits bacterial growth and C/EBPδ−/−
mice succumb due to the infection at an earlier time point
as compared to wild-type mice [12]. Similar to these find-
ings, increased C/EBPδ expression during K. pneumoniae-
induced pulmonary infection was found to contribute to
improved survival as evident from reduced survival of C/
EBPδ−/− mice [13]. In contrast, increased C/EBPδ expres-
sion during urinary tract infection did not affect diseaseFigure 4 Effect of C/EBPδ deficiency on the clinical status during
pneumococcal meningitis. Clinical scores of wild-type and C/EBPδ−/−
mice at different time points during meningitis. A.U. = arbitrary units;
dashed line indicates the maximal score of 15.progression nor outcome [15]. C/EBPδ expression also
contributed to bacterial outgrowth and dissemination lead-
ing to prolonged survival of C/EBPδ−/− mice during S.
pneumoniae-induced pulmonary infection [14]. This is in
line with our results showing that bacterial dissemination
was hampered in C/EBPδ−/− mice as compared to wild-
type mice during pneumococcal meningitis leading to a
lower bacterial burden in blood and peripheral organs. C/
EBPδ-driven bacterial dissemination during meningitis did,
however, not modify clinical parameters of meningitis and
did not affect overall survival, whereas C/EBPδ-driven dis-
semination during pneumonia was detrimental. These data
underscore the fact that C/EBPδ-driven dissemination
plays a divergent role during infectious disease leading to
different outcome of the disease.
In our study, we confirm the established role of C/EBPδ
as activator of the inflammatory response, reflected by the
reduction in IL-10 and KC levels in the brain and IL-6, IL-
10, KC, and MIP-2 in plasma during pneumococcal men-
ingitis. The reduced levels of inflammatory mediators in
C/EBPδ−/− mice during meningitis may be a direct conse-
quence of C/EBPδ-driven transcriptional activity but may
also be a mere reflection of the bacterial burden. Indeed,
the extent of inflammation closely follows the bacterial
burden during experimental pneumococcal pneumonia
[20,21], although such a correlation has not been estab-
lished for pneumococcal meningitis yet. Here, we show
for the first time that during meningitis cytokine and che-
mokine levels also positively correlate with the bacterial
burden in the brain of wild-type mice (id est IL-6, TNF-α,
IL-1β, IL-10, KC, and MIP-2). However, such a correlation
is not observed for IL-6, IL-10, and KC in C/EBPδ−/−
mice, which suggests that C/EBPδ directly drives tran-
scriptional activity of these inflammatory mediators during
meningitis. This is in line with previous reports showing
that C/EBPδ is involved in the regulation of IL-6 [12,22]
and IL-10 [23] after LPS stimulation, although C/EBPδ
suppresses IL-10 expression in dendritic cells of the cen-
tral nervous system in an animal model of multiple scler-
osis [24]. Moreover, TNF-α and MIP-2 levels are not
dependent on C/EBPδ during pneumococcal meningitis,
although these cytokines have been shown to be regulated
by C/EBPδ during LPS-induced models of acute lung in-
jury [22] and endotoxemia [25]. We currently have no
proper explanation for these seeming contradictive results,
although the role of C/EBPδ in the inflammatory response
might strongly depend on the underlying disease.
Our results show that the C/EPBδ-mediated inflamma-
tory response is not a major mechanism explaining poor
outcome in pneumococcal meningitis. We did not find
differences in survival nor clinical parameters between
wild-type and C/EBPδ−/− mice. Apparently, the lower bac-
terial burden in combination with the lower inflammatory
response in C/EBPδ−/− did not affect clinical parameters
Figure 5 Effect of C/EBPδ deficiency on organ damage during pneumococcal meningitis. Levels of general tissue injury marker lactate dehydrogenase
(LDH; A), liver injury markers alanine transaminase (ALAT; B) and aspartate transaminase (ASAT; C) in plasma of wild-type (open boxes) and C/EBPδ−/− (gray
boxes) 30 h after infection. Data are expressed as median with interquartile ranges and 5% to 95% percentiles. *P < 0.05 compared to wild-type
control mice.
Serón et al. Journal of Neuroinflammation  (2015) 12:88 Page 7 of 8of meningitis. In a previous study, reduced bacterial loads
did correlate with improved survival during S. pneumoniae-
induced meningitis. Formyl peptide receptor (FPR)-1 or -2
deficient mice had higher bacterial titers than wild-type
mice after pneumococcal meningitis, and wild-type mice
lived significantly longer than both knockout strains [26].
Although we do not have a clear explanation for these dif-
ferent results at the moment, gender differences (male
mice in the FPR study and female mice in our study) and/
or used pathogens (type 2 vs. type 3 S. pneumoniae in the
FPF and our study, respectively) may explain at least part
of the observed differences. A possible explanation for the
discrepancy between clinical outcome and decreased bac-
terial burden and lower inflammatory response observed
in this study could be that C/EBPδ also plays a crucial role
in neuroprotective processes. Indeed, levels of IL-10, an
important anti-inflammatory mediator with a protective
function in pneumococcal meningitis [7], are significantly
decreased in C/EBPδ−/− mice as compared to wild-type
mice. Although reduced IL-10 levels may thus explain the
lack of effect on clinical parameters, alternative, currently
unknown, neuroprotective properties of C/EBPδ in the
brain cannot be excluded.Figure 6 Effect of C/EBPδ deficiency on blood-brain barrier status and survival
boxes) 30 h after infection. Data are expressed as median with interquartile ran
mice (A). Survival of wild-type (black circle) and C/EBPδ−/− mice (black square)Our study has several limitations. First, we only stud-
ied a single dose of a single serotype pneumococcus. As
the virulence of different pneumococcal serotypes var-
ies widely, experimental meningitis due to other sero-
types may yield different results. Furthermore, using
different inoculum sizes may show more subtle differ-
ences. However, our model uses the most common
serotype found in patients with pneumococcal meningi-
tis, and the used inoculation size results in a mortality
similar to that observed in patients [17,4]. Therefore,
we feel that our model provides sufficient information
to conclude there is a lack of effect on survival of C/
EBPδ. Second, we did not treat our mice with antibiotic
therapy, and therefore our model does not reflect the
clinical situation. However, the aim of our study was to
further study the role of C/EBPδ in the pathophysiology
of pneumococcal meningitis, which is best evaluated in
untreated models.
In conclusion, we show that C/EBPδ expression in-
creases in the brain of mice during meningitis and that
C/EBPδ−/− expression contributes to bacterial growth
and/or dissemination and induces the inflammatory
response. C/EBPδ expression did not affect clinical. Brain/plasma albumin ratio in wild-type (open boxes) and C/EBPδ−/− (gray
ges and 5% to 95% percentiles. *P < 0.05 compared to wild-type control
after induction of pneumococcal meningitis (n = 12 mice per group; B).
Serón et al. Journal of Neuroinflammation  (2015) 12:88 Page 8 of 8parameters nor did it change survival suggesting that
C/EBPδ plays complex role in S. pneumoniae-induced
meningitis.
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